More real world data suggests that GLP-1 drugs, which are reputed to aid the bodys cancer killing cells, may reduce the risk of colorectal, prostate, and liver cancer, too, says Drucker
Head-to-Head Superiority (SURMOUNT-5): The SURMOUNT-5 trial, with detailed results published in The New England Journal of Medicine on May 11, 2025, directly compared Tirzepatide (Zepbound) with semaglutide (Wegovy)
Although this study only featured the data from one person taking tirzepatide, it provides compelling data about how GLP-1 and GIP inhibitors alter electrical signals in the brain, said study co-first author Wonkyung Choi, a PhD candidate at the University of Pennsylvania School of Medicine in Philadelphia
Why Semaglutide Causes Nausea and How Your Body Adapts Semaglutide activates GLP-1 receptors in the brain and digestive tract, which signals your stomach to contract more slowly and signals your appetite center that you are full